Michael A. Morse

Michael A. Morse

Auto-generated profile, based on publicly available information

Michael A. Morse

Ascension Saint Thomas, Nashville, TN (M.A.M.M., E.R.).

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2023 in US Cardiology Review
Verified
Journal Article
Open access
PDF file
JKJimmy Kerrigan
Jimmy Kerrigan
TPTimir K Paul
Timir K Paul
JPJay Patel
Jay Patel
WSWalid Saad
Walid Saad
AMAndrew Morse
Andrew Morse
HLHady Lichaa
Hady Lichaa
Vascular access is a crucial step, which every interventional cardiologist needs to be skilled with to consistently achieve excellent periprocedural outcomes. Some operators argue that it is the most important aspect of the entire intervention. Hence, careful planning of vascular access in an individualized fashion – based on the patient’s clinical status, anatomy, and technical requirements of the intervention – is the first step in securing optimal procedural safety and successful results. We briefly review multiple aspects of vascular access and management including site selection, ultrasound guidance, micro-puncture techniques, sheathless techniques, limb perfusion, clinical monitoring, large bore closure, and management of complications. Approaching every vascular access in a systematic way, even in emergent situations, allows operators to minimize the risk of complications, especially in an often severely ill patient population.

1 February 2026 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
MRMark J. Ricciardi
Mark J. Ricciardi
GSGagan Singh
Gagan Singh
JRJason H. Rogers
Jason H. Rogers
TRTobias Ruf
Tobias Ruf
WRWolfgang Rottbauer
Wolfgang Rottbauer
SKSaibal Kar
Saibal Kar
BACKGROUND: Atrial secondary mitral regurgitation (aSMR) is a distinct subtype of SMR characterized by normal leaflets, annular dilatation, left atrial (LA) enlargement, and preserved left ventricular function. Treatment pathways for aSMR are undefined, and limited data exist regarding outcomes following mitral transcatheter edge-to-edge repair (MTEER). The analysis aimed to evaluate outcomes in patients with aSMR treated with MTEER from the EXPANDed (Evaluation of the MitraClip X System Post-MArket Real-World CliNical Outcomes Database ) studies. METHODS: One-year outcomes were assessed in patients from the EXPANDed studies (EXPAND and EXPAND G4 [Evaluation of the MitraClip X System Post-MArket Real-World CliNical Outcomes Database Generation 4 ]) who met criteria for aSMR. aSMR was defined by the presence of atrial fibrillation, left ventricular ejection fraction ≥45%, and at least 1 dilated LA parameter per echocardiographic core laboratory assessment: LA volume index, LA diameter, or LA diameter index. RESULTS: Of the 967 patients with SMR treated with MTEER in the EXPANDed data set, 160 (17%) met criteria for aSMR. Patients with aSMR were elderly (78±8 years), symptomatic (Kansas City Cardiomyopathy Questionnaire Overall Summary score, 48±27 pts), and had small left ventricular and large LA dimensions at baseline. Acute procedural success was achieved in 97.5% of patients with aSMR, with MR reduction to ≤1+ in 95.2% at 1 year. There were significant 1-year improvements in quality of life (+19 pt Kansas City Cardiomyopathy Questionnaire Overall Summary) and functional capacity (New York Heart Association I/II 80%). The 1-year all-cause mortality rate was 9%, with patients experiencing a 56% reduction in 1-year heart failure hospitalization rates from pre- to post-MTEER. CONCLUSIONS: In the largest population of patients with aSMR assessed by an echocardiographic core laboratory, MTEER safely and significantly reduced MR with improvements in quality of life and reduction in heart failure hospitalization through 1 year.

1 February 2025 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
NDNeal M. Duggal
Neal M. Duggal
MEMilo Engoren
Milo Engoren
PSPaul Sorajja
Paul Sorajja
DLD. Scott Lim
D. Scott Lim
JRJason H. Rogers
Jason H. Rogers
GAGorav Ailawadi
Gorav Ailawadi
BACKGROUND: The association, if any, between the transmitral mean pressure gradient (TMPG) after mitral transcatheter edge-to-edge repair and 1-year mortality is controversial in patients undergoing mitral transcatheter edge-to-edge repair with the MitraClip system. We sought to estimate the association between intraoperatively measured residual mitral regurgitation (rMR) and TMPG and 1-year mortality among patients undergoing mitral transcatheter edge-to-edge repair to facilitate decisions on additional devices. METHODS: In patients with severe secondary (functional) MR, we analyzed registry data using generalized estimating equations. Both rMR and TMPG were nonlinearly transformed using fractional polynomials. RESULTS: We studied 570 patients with secondary MR who underwent mitral transcatheter edge-to-edge repair in 11 centers. Most patients were men (61%) and averaged 72±12 years of age. Most (78%) patients had TMPG <5 mm Hg and 22% had TMPG ≥5 mm Hg. Postprocedural MR severity improved substantially, being ≤2+ in 95% (with ≤1+ in 76%), 3+ in 3%, and 4+ in 2%. 1-year mortality was 20%. After adjustment for confounders, rMR (odds ratio, 2.10 [95% CI, 1.88–2.35]; P <0.001 for rMR .5 ) and TMPG remained associated with mortality, with odds ratios of 1.26 (95% CI, 1.19–1.32), 1.84 (1.58–2.10), and 3.13 (2.31–3.98) for TMPG values of 4, 6, and 8, respectively, compared with TMPG=2 mm Hg at rMR=1+. CONCLUSIONS: Both rMR and TMPG were nonlinearly associated with 1-year mortality. At low levels of rMR, changes in TMPG are associated with only small changes in the risk of death. Conversely, at higher levels of rMR, even small changes in TMPG are associated with larger changes in the absolute risk of death.

3 April 2023
Verified
Other
Open access
MKMickey K. Kim
Mickey K. Kim
TOTakuya Osada
Takuya Osada
WBWilliam T. Barry
William T. Barry
XYXiao Yi Yang
Xiao Yi Yang
JFJennifer A. Freedman
Jennifer A. Freedman
DHDavid S. Hsu
David S. Hsu